Stockreport

Merck (MRK) Reports Strong Phase 3 Results for Oral PCSK9 [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck (MRK) Reports Strong Phase 3 Results for Oral PCSK9 On March 30, 2026, Merck & Co., Inc. (NYSE:MRK) announced positive Phase 3 CORALreef AddOn trial results for [Read more]